Fundraising FoxBiosortia Pharmaceuticals
1 known investors
Find your way into Biosortia Pharmaceuticals
Sign up to see every warm intro you have to Biosortia Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Biosortia Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Biosortia develops an aquatic natural products drug discovery platform, leveraging marine organisms to identify pharmaceutical compounds for various therapeutic areas.
Founders & leadership
RO
Ross O. YoungsFounder and CEORoss O. Youngs is founder and CEO of Biosortia, which develops a marine microbiome-based platform for drug discovery. He has founded multiple companies and holds over 75 international patents, with prior recognition including SBA National Business Person of the Year (1998) and Ernst & Young Entrepreneur of the Year for Ohio.
Investors · 1
In the news
Frequently asked questions
- What does Biosortia Pharmaceuticals do?
- Biosortia develops an aquatic natural products drug discovery platform, leveraging marine organisms to identify pharmaceutical compounds for various therapeutic areas.
- Who founded Biosortia Pharmaceuticals?
- Biosortia Pharmaceuticals was founded by Ross O. Youngs.
- Who are Biosortia Pharmaceuticals's investors?
- Biosortia Pharmaceuticals's investors include Keiretsu Forum.